(Q39389208)

11 September 2017

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms (English)

1 reference

11 September 2017

Y-N Liu

1

1 reference

11 September 2017

J J Yin

2

1 reference

11 September 2017

W Abou-Kheir

3

1 reference

11 September 2017

P G Hynes

4

1 reference

11 September 2017

O M Casey

5

1 reference

11 September 2017

L Fang

6

1 reference

11 September 2017

M Yi

7

1 reference

11 September 2017

R M Stephens

8

1 reference

11 September 2017

V Seng

9

1 reference

11 September 2017

H Sheppard-Tillman

10

1 reference

11 September 2017

P Martin

11

1 reference

11 September 2017

K Kelly

12

1 reference

11 September 2017

language of work or name

English

0 references

publication date

27 February 2012

1 reference

11 September 2017

1 reference

11 September 2017

32

1 reference

11 September 2017

296-306

1 reference

11 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.58

11 September 2017

0 references

cites work

Epithelial-mesenchymal transitions in development and disease

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

N-cadherin switching occurs in high Gleason grade prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

TGF-beta-induced epithelial to mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Sarcomatoid carcinoma of the prostate: a study of 42 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Slug gene expression supports human osteoblast maturation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Role of Slug transcription factor in human mesenchymal stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.58

Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22370643

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2012.58

1 reference

Dimensions Publication ID

11 September 2017

0 references

0 references

1 reference